Anemic syndrome and its features in patients with disseminated pulmonary tuberculosis and HIV infection

DOI: https://doi.org/10.29296/25877305-2021-02-12
Download full text PDF
Issue: 
2
Year: 
2021

E. Yakovleva Samara State Medical University, Ministry of Health of Russia

Currently, the incidence of HIV infection and pulmonary tuberculosis (PT) comorbidity is increasing, with disseminated PT making up a major proportion in the pattern of clinical forms of PT. Anemic syndrome is one of the possible complications of both tuberculosis and HIV infection. Objective: to investigate the features of anemic syndrome in patients with disseminated PT/HIV infection comorbidity. Subjects and methods. The investigation enrolled 42 patients with HIV infection and disseminated PT. The patients’ clinical and social characteristics were studied; the values of a general blood test were analyzed. Serum iron, ferritin, and hepcidin levels were additionally determined. Statistical data were processed using the MedCalc 19.2.6 statistical software program. Results. The patients with HIV infection and disseminated PT were found to have anemia, mainly hypo- or normochromic moderate anemia, in half of the cases. There was a preponderance of anemia of chronic disease (47.6%), mixed anemia (38.1%), whereas true iron deficiency anemia was rare (4.8%). Conclusion. The findings may further contribute to the choice of tactics for the correction of anemic syndrome in patients with HIV infection and disseminated PT.
Keywords: 
phthisiology
infectious diseases
disseminated pulmonary tuberculosis
HIV infection
anemia
serum iron
ferritin
hepcidin

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Vdoushkina E.S., Borodulina E.A., Kalinkin A.V. i dr. Tuberkulez u bol'nyh VICh-infektsiej v regione s vysokim rasprostraneniem VICh. Tuberkulez i bolezni legkih. 2018; 96 (12): 64–5 [Vdoushkina E.S., Borodulina E.A., Kalinkin A.V. et al. Tuberculosis in HIV patients in the region with high HIV prevalence. Tuberculosis and Lung Diseases. 2018; 96 (12): 64–5 (in Russ.)]. DOI: 10.21292/2075-1230-2018-96-12-64-65
  2. Borodulina E.A., In'kova A.T., Borodulin B.E. i dr. Puti optimizatsii vyjavlenija tuberkuleza v pul'monologicheskom otdelenii. Tuberkulez i bolezni legkih. 2018; 96 (5): 22–7 [Borodulina E.A., Inkova A.T., Borodulin B.E., Povalyaeva L.V. Ways to optimize detection of tuberculosis in a pulmonology unit. Tuberculosis and Lung Diseases. 2018; 96 (5): 22–7 (in Russ.)]. DOI: 10.21292/2075-1230-2018-96-5-22-26
  3. Borodulina E.A., Jakovleva E.V. Disseminirovannyj tuberkulez legkih: sovremennye aspekty. Nauka i innovatsii v meditsine. 2017; 2 (2): 39–43 [Borodulina E.A., Yakovleva E.V. Disseminated pulmonary tuberculosis: actual problems. Science and Innovations in Medicine. 2017; 2 (2): 39–43 (in Russ.)]. DOI: 10.35693/2500-1388-2017-0-2-39-43
  4. Il'kovich M.M., Novikova L.N., Il'kovich Ju.M. Protivorechija v predstavlenijah ob interstitsial'nyh zabolevanijah legkih. Doktor.Ru. 2013; 8 (86): 41–5 [Il’kovich M.M., Novikova L.N., Il’kovich Yu.M. Discrepancies in Understanding Interstitial Lung Disease. Doktor.Ru. 2013; 8 (86): 41–5 (in Russ.)].
  5. Mishin V.Ju., Ergeshov A.E., Mishina A.V. Diagnostika i differentsial'naja diagnostika disseminirovannyh porazhenij legkih u bol'nyh s VICh-infektsiej (obzor). Consilium Medicum. 2018; 20 (3): 8–13 [Mishin V.Yu., Ergeshov A.E., Mishina A.V. Diagnosis and differential diagnosis of disseminated lung lesions in patients with HIV infection (review). Consilium Medicum. 2018; 20 (3): 8–13 (in Russ.)]. DOI: 10.26442/2075-1753_20.3.8-13
  6. Borodulina E.A., Vdoushkina E.S., In'kova A.T. Tuberkulez legkih u bol'nyh VICh-infektsiej. Vrach. 2020; 31 (1): 37–43 [Borodulina E., Vdoushkina E., Inkova A. Tuberculosis and HIV-infection. Vrach. 2020; 31 (1): 37–43 (in Russ.)]. DOI: 10.29296/25877305-2020-01-07
  7. Kaminskij G.D., Kudlaj D.A., Panova A.E. i dr. Taktika vracha pri vyjavlenii, diagnostike i profilaktike sochetannoj infektsii VICh i tuberkulez. Prakticheskoe rukovodstvo. Pod red. I.A. Vasil'evoj. M., 2020; 152 s. [Kaminskii G.D., Kudlai D.A., Panova A.E. et al. Taktika vracha pri vyyavlenii, diagnostike i profilaktike sochetannoi infektsii VICh i tuberkulez. Prakticheskoe rukovodstvo. Pod red. I.A. Vasil’evoi. M., 2020; 152 s. (in Russ.)].
  8. Kudlaj D.A. Biomarkery i immunologicheskie testy. Eksperimental'no-klinicheskie paralleli latentnoj tuberkuleznoj infektsii. Tuberkulez i bolezni legkih. 2020; 98 (8): 63–74 [Kuday D.A. Biomarkers and immunological tests. Experimental and clinical parallels of latent tuberculosis infection. Tuberculosis and Lung Diseases. 2020; 98 (8): 63–74 (in Russ.)]. http://doi.org/10.21292/2075-1230-2020-98-8-63-74
  9. Cardona P.J. Pathogenesis of tuberculosis and other mycobacteriosis. Enferm Infec Microbiol Clin. 2018; 36 (1): 38–46. DOI: 10.1016/j.eimc.2017.10.015
  10. Sharma S., Nahar U., Das A. et al. Acute respiratory distress syndrome in disseminated tuberculosis: an uncommon association. Int J Tuberc Lung Dis. 2016; 20 (2): 271–5. DOI: 10.5588/ijtld.15.0357
  11. Abreu R., Essler L., Loy A. et al. Heparin inhibits intracellular Mycobacterium tuberculosis bacterial replication by reducing iron levels in human macrophages. SciRep. 2018; 8 (1): 72–96. DOI: 10.1038/s41598-018-25480-y
  12. Mendonça E.B., Schmaltz C.A., Sant’Anna F.M. et al. Anemia in tuberculosis cases: A biomarker of severity? PLoS One. 2021; 16 (2): 54–8. DOI: 10.1371/journal.pone.0245458
  13. Agafonova O.V., Gritsenko T.A., Bogdanova Ju.V. i dr. Poliklinicheskaja terapija: Uchebnik. Pod red. D.I. Davydkina, Ju.V. Schukina. 2-e izd., pererab. i dop. M.: GEOTAR-Media, 2020; 840 s. [Agafonova O.V., Gritsenko T.A., Bogdanova Yu.V. et al. Poliklinicheskaya terapiya: Uchebnik. Pod red. D.I. Davydkina, Yu.V. Shchukina. 2-e izd., pererab. i dop. M.: GEOTAR-Media, 2020; 840 s. (in Russ.)] DOI: 10.33029/9704-5545-6-PLT-2020-1-840
  14. Andreichev N.A., Baleeva L.V. Anemija hronicheskih zabolevanij. Rossijskij meditsinskij zhurnal. 2014; 20 (2): 50–5 [Andreitchev N.A., Baleyeva L.V. Anemia of chronic diseases. Medical Journal of the Russian Federation. 2014; 20 (2): 50–5 (in Russ)].
  15. Sahin V.T., Krjukov E.V., Rukavitsyn O.A. Anemija hronicheskih zabolevanij – osobennosti patogeneza i popytka klassifikatsii. Tihookeanskij meditsinskij zhurnal. 2019; 1: 33–7 [Sakhin V.T., Kryukov E.V., Rukavitsyn O.A. Anemia of chronic diseases – the key mechanisms of pathogenesis and the attempt of the classification. Pacific Medical Journal. 2019; 1: 33–7 (in Russ.)]. DOI: 10.17238/PmJ1609-1175.2019.1.33–37
  16. Erika P., Margherita M., Motta I. Anemia of chronic disease: a unique defect of iron recycling for many different chronic diseases. Eur J Intern Med. 2014; 25 (1): 12–7. DOI: 10.1016/j.ejim.2013.07.011
  17. Cassat J.E., Skaar E.P. Iron in infection and immunity. Cell Host Microb. 2013; 13 (5): 509–19. DOI: 10.1016/j.chom.2013.04.010
  18. Kerkhoff A.D., Meintjes G., Burton R. et al. Relationship between blood concentrations of hepcidin and anemia severity, mycobacterial burden, and mortality among patients with HIV-associated tuberculosis. Infect Dis. 2016; 213 (1): 61–70. DOI: 10.1093/infdis/jiv364